BHC:NYE-Bausch Health Companies Inc (USD)

COMMON STOCK | Drug Manufacturers-Specialty & Generic | NYE

Last Closing Price

USD 10.77

Change

-0.07 (-0.65)%

Market Cap

USD 3.92B

Volume

7.10M

Avg Analyst Target

USD 19.50 (+81.06%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Bausch Health Companies Inc (BHC) Stock Analysis:
Based on the Bausch Health Companies Inc stock forecasts from 3 analysts, the average analyst target price for Bausch Health Companies Inc is USD 19.50 over the next 12 months. Bausch Health Companies Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bausch Health Companies Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Bausch Health Companies Inc’s stock price was USD 10.77. Bausch Health Companies Inc’s stock price has changed by -16.51% over the past week, -51.42% over the past month and -62.95% over the last year.

About

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operat ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-16 )

Largest Industry Peers for Drug Manufacturers-Specialty & Generic

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS Zoetis Inc

+0.17 (+0.10%)

USD77.81B 38.72 24.63
TAK Takeda Pharmaceutical Company ..

-0.07 (-0.49%)

USD44.50B 13.27 0.06
CTLT Catalent Inc

-0.51 (-0.52%)

USD17.42B 29.47 18.25
ELAN Elanco Animal Health Incorpora..

+1.04 (+4.67%)

USD10.56B 144.89 31.26
TEVA Teva Pharmaceutical Industries..

+0.15 (+1.93%)

USD8.74B 20.53 17.60
RDY Dr. Reddy's Laboratories Limit..

-0.18 (-0.35%)

USD8.34B 24.54 0.17
PRGO Perrigo Company plc

+0.58 (+1.58%)

USD4.95B 24.33 9.44
EBS Emergent BioSolutions Inc

-0.12 (-0.42%)

USD1.44B 9.69 4.82
TARO Taro Pharmaceutical Industries..

+0.61 (+1.64%)

USD1.40B 1,327.14 10.99
AMRX Amneal Pharmaceuticals Inc

-0.02 (-0.58%)

USD1.05B 49.29 8.40

ETFs Containing BHC

Symbol Name Weight Mer Price(Change) Market Cap
MJJ MicroSectors Cannabis ETN.. 9.90 % 0.70 %

N/A

N/A
MJO MicroSectors Cannabis 2X .. 9.90 % 0.95 %

N/A

N/A
PPA Invesco Aerospace & Defen.. 6.03 % 0.61 %

+0.12 (+0.17%)

USD1.45B
GNOM Global X Genomics & Biote.. 5.36 % 0.50 %

-0.21 (-1.78%)

USD0.13B
EDOC Global X Telemedicine & D.. 5.24 % 0.68 %

-0.15 (-1.28%)

N/A
DFEN Direxion Daily Aerospace .. 4.59 % 1.01 %

-0.11 (-0.70%)

USD0.21B
OSXC:F Ossiam Lux - Ossiam Risk .. 4.58 % 0.45 %

+0.66 (+0.58%)

USD9.90M
DDOC:XETRA Global X Telemedicine & D.. 4.58 % 0.68 %

-0.05 (-0.52%)

N/A
CRWE:PA Ossiam Lux - Ossiam Risk .. 4.58 % 0.45 %

+1.54 (+1.35%)

USD9.90M
OSXC:XETRA Ossiam Lux - Ossiam Risk .. 4.58 % 0.45 %

+1.54 (+1.35%)

USD9.90M
ZWA:CA BMO Covered Call Dow Jone.. 4.57 % 0.65 %

+0.08 (+0.33%)

USD0.20B
EXI3:F iShares Dow Jones Industr.. 4.57 % 0.51 %

-1.60 (-0.52%)

USD0.25B
EXI3:XETRA iShares Dow Jones Industr.. 4.57 % 0.51 %

-1.20 (-0.39%)

USD0.25B
ZDJ:CA BMO Dow Jones Industrial .. 4.57 % 0.26 %

+0.01 (+0.02%)

USD0.30B
SXRU:F iShares VII Public Limite.. 4.56 % 0.33 %

-0.50 (-0.14%)

USD0.80B
SXRU:XETRA iShares VII Public Limite.. 4.56 % 0.33 %

-1.35 (-0.38%)

USD0.80B
HIG:CA Brompton Global Healthcar.. 4.46 % 0.97 %

+0.03 (+0.32%)

USD0.05B
1546:TSE NEXT FUNDS Dow Jones Indu.. 4.41 % 0.40 %

+170.00 (+0.42%)

USD20.35B
FMK First Trust Mega Cap Alph.. 4.35 % 0.70 %

N/A

USD0.02B
ZPDI:F SSgA SPDR ETFs Europe II .. 4.24 % 0.15 %

-0.21 (-0.55%)

USD0.29B
2B7C:XETRA iShares V Public Limited .. 4.24 % 0.15 %

-0.06 (-0.78%)

USD0.24B
ZPDI:XETRA SSgA SPDR ETFs Europe II .. 4.24 % 0.15 %

-0.28 (-0.76%)

USD0.29B
FIW First Trust Exchange-Trad.. 3.95 % 0.54 %

-0.28 (-0.38%)

USD1.25B
SXLI:LSE SSgA SPDR ETFs Europe II .. 3.48 % 0.15 %

-0.32 (-0.83%)

USD0.29B
XLI Industrial Select Sector .. 3.04 % 0.10 %

-0.13 (-0.14%)

USD14.43B
IUIS:LSE iShares S&P 500 Industria.. 2.97 % 0.15 %

-0.06 (-0.82%)

USD0.24B
IISU:LSE iShares V Public Limited .. 2.97 % 0.15 %

-5.25 (-0.86%)

USD0.24B
ZGEN:CA BMO MSCI Genomic Innovati.. 2.91 % 0.40 %

N/A

N/A
VIS Vanguard Industrials Inde.. 2.64 % 0.10 %

-0.47 (-0.27%)

USD4.28B
FIDU Fidelity Covington Trust .. 2.36 % 0.08 %

-0.12 (-0.25%)

USD0.76B
XGI:CA iShares S&P Global Indust.. 2.23 % 0.65 %

-0.27 (-0.71%)

USD0.07B
XDWI:F Xtrackers (IE) Public Lim.. 2.16 % 0.25 %

-0.21 (-0.51%)

USD0.39B
XDWI:XETRA Xtrackers (IE) Public Lim.. 2.16 % 0.25 %

-0.29 (-0.70%)

USD0.39B
XDWI:LSE Xtrackers (IE) Public Lim.. 1.81 % 0.25 %

-0.26 (-0.62%)

USD0.39B
WNDU:LSE SPDR® MSCI World Industr.. 1.78 % 0.30 %

-0.31 (-0.64%)

USD0.06B
DUSL Direxion Shares ETF Trust.. 1.74 % 0.99 %

-0.21 (-0.68%)

USD0.03B
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.86 % 0.30 %

-0.17 (-0.51%)

USD0.10B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.84 % 0.30 %

-0.26 (-0.67%)

USD0.14B
SYBK:XETRA SSgA SPDR ETFs Europe I p.. 0.84 % 0.30 %

-0.12 (-0.32%)

USD0.14B
SJNK:LSE SSgA SPDR ETFs Europe I p.. 0.74 % 0.30 %

-0.18 (-0.44%)

USD0.10B
XRSM:F Xtrackers (IE) Public Lim.. 0.40 % 0.02 %

-0.05 (-0.16%)

USD0.11B
XRSM:XETRA Xtrackers (IE) Public Lim.. 0.40 % 0.02 %

-0.24 (-0.76%)

USD0.11B
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.30 %

-0.08 (-0.37%)

N/A
SHLD Victory Portfolios II - V.. 0.00 % 0.60 %

N/A

USD3.32M
BND Vanguard Bond Index Funds.. 0.00 % 0.04 %

+0.12 (+0.16%)

USD286.54B
CIND:LSE iShares VII Public Limite.. 0.00 % 0.33 %

-1.84 (-0.49%)

USD0.80B
SYBJ:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.40 %

-0.07 (-0.14%)

USD0.47B
SJB ProShares Trust - ProShar.. 0.00 % 0.95 %

+0.03 (+0.16%)

USD0.24B
CJNK SPDR ICE BofAML Broad Hig.. 0.00 % 0.15 %

N/A

USD0.07B
DDM ProShares Ultra Dow30 0.00 % 0.95 %

+0.21 (+0.34%)

USD0.41B
DIA SPDR Dow Jones Industrial.. 0.00 % 0.16 %

+0.55 (+0.17%)

USD28.42B
EXI iShares Global Industrial.. 0.00 % 0.43 %

-0.15 (-0.14%)

USD0.34B
HYG iShares Trust - iShares i.. 0.00 % 0.48 %

-0.11 (-0.14%)

USD12.55B
HYLS First Trust Tactical High.. 0.00 % 1.13 %

-0.21 (-0.50%)

USD1.92B
IWP iShares Russell Mid-Cap G.. 0.00 % 0.23 %

-1.57 (-1.87%)

USD12.01B
RFUN ALPS ETF Trust - Riverfro.. 0.00 % 0.55 %

N/A

USD0.01B
UDOW ProShares Trust - ProShar.. 0.00 % 0.95 %

+0.25 (+0.44%)

USD0.72B
BSJL Invesco BulletShares 2021.. 0.00 % 0.42 %

N/A

USD0.55B
UXI ProShares Ultra Industria.. 0.00 % 0.95 %

-0.12 (-0.53%)

USD0.02B
VNLA Janus Henderson Short Dur.. 0.00 % 0.23 %

-0.01 (-0.02%)

USD2.54B
XAR SPDR S&P Aerospace & Defe.. 0.00 % 0.35 %

-0.90 (-0.85%)

USD1.61B
HYLB Xtrackers USD High Yield .. 0.00 % 0.15 %

-0.04 (-0.11%)

USD4.19B
BSJP Invesco BulletShares 2025.. 0.00 % 0.42 %

-0.06 (-0.26%)

USD0.34B
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

-0.06 (-0.14%)

USD0.09B
HYGV FlexShares Trust - FlexSh.. 0.00 % 0.37 %

-0.13 (-0.30%)

USD0.88B
PHYL PGIM Active High Yield Bo.. 0.00 % 0.53 %

-0.12 (-0.32%)

USD0.09B
ROKT SPDR Kensho Final Frontie.. 0.00 % 0.45 %

+0.01 (+0.03%)

USD0.02B
ZHDG ZEGA Buy and Hedge ETF 0.00 % 1.02 %

-0.05 (-0.28%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-Specialty & Generic)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -60.99% 13% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.99% 13% F 3% F
Trailing 12 Months  
Capital Gain -63.18% 27% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -63.18% 27% F 5% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.07% 59% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.07% 59% F 50% F
Risk Return Profile  
Volatility (Standard Deviation) 36.55% 41% F 29% F
Risk Adjusted Return 22.07% 65% D 30% F
Market Capitalization 3.92B 53% F 71% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-Specialty & Generic)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 5.11 100% A+ 89% B+
Price/Book Ratio 18.78 7% F 3% F
Price / Cash Flow Ratio 2.75 60% D- 68% D+
EV/EBITDA 11.58 50% F 46% F
Management Effectiveness  
Return on Equity -328.20% 13% F 1% F
Return on Invested Capital 2.28% 47% F 34% F
Return on Assets 3.54% 60% D- 60% D-
Debt to Equity Ratio -21,371.70% 100% A+ 99% A+
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 3.46 67% D+ 31% F
Short Percent 4.59% 33% F 44% F
Beta 1.60 7% F 18% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector